Compare BEAM & TNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BEAM | TNK |
|---|---|---|
| Founded | 2017 | 2007 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.5B |
| IPO Year | 2019 | 2007 |
| Metric | BEAM | TNK |
|---|---|---|
| Price | $23.08 | $89.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 5 |
| Target Price | $49.85 | ★ $109.00 |
| AVG Volume (30 Days) | ★ 1.8M | 416.3K |
| Earning Date | 11-03-2026 | 11-11-2026 |
| Dividend Yield | N/A | ★ 1.13% |
| EPS Growth | ★ 82.31 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $24,000.00 | N/A |
| Revenue This Year | N/A | $47.47 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.05 |
| Revenue Growth | ★ 33.33 | N/A |
| 52 Week Low | $20.23 | $50.94 |
| 52 Week High | $38.26 | $110.65 |
| Indicator | BEAM | TNK |
|---|---|---|
| Relative Strength Index (RSI) | 40.33 | 44.10 |
| Support Level | $22.65 | $71.28 |
| Resistance Level | $28.19 | $94.44 |
| Average True Range (ATR) | 1.92 | 4.09 |
| MACD | -0.33 | -0.65 |
| Stochastic Oscillator | 0.07 | 36.65 |
Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.
Teekay Tankers Ltd is a provider of marine services to the international oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: Tankers, which consists of the operation of all of the company's tankers (including the operations from those tankers employed on full service lightering contracts), and the company's U.S. based ship-to-ship support service operations (including its lightering support services provided as part of full service lightering operations); and Marine Services, which consists of operational and maintenance marine services provided to the Australian government, Australian energy companies and other third parties. The company generates the majority of its revenue from the Tankers segment.